These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29253053)

  • 1. New Epidemiologic Data Regarding Hepatitis C Virus Infection in Romania.
    Manuc M; Preda CM; Popescu CP; Baicuș C; Voiosu T; Pop CS; Gheorghe L; Sporea I; Trifan A; Tanțău M; Tanțău A; Ceaușu E; Proca D; Constantinescu I; Ruta SM; Fulger LE; Diculescu M; Oproiu A
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):381-386. PubMed ID: 29253053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C.
    Grigorescu M;
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):45-50. PubMed ID: 19337633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV non-1b genotypes in injecting drug users from Romania.
    Ruta S; Sultana C; Oprea C; Vagu C; Ceausu E; Cernescu C
    J Infect Dev Ctries; 2016 May; 10(5):523-7. PubMed ID: 27249529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study.
    Semenova T; Nemoz B; Thibault V; Lagathu G; Duverlie G; Brochot E; Trimoulet P; Payan C; Vallet S; Henquell C; Chevaliez S; Bouvier-Alias M; Maylin S; Roque-Afonso AM; Izquierdo L; Lunel-Fabiani F; Marcellin P; Morand P; Leroy V; Larrat S
    Epidemiol Infect; 2019 Jan; 147():e234. PubMed ID: 31364570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution of hepatitis C virus genotypes among patients with chronic hepatitis C infection in Akdeniz University Hospital, Antalya, Turkey: a five-year evaluation].
    Sağlik İ; Mutlu D; Öngut G; İnan D; Öğünç D; Can Sarinoğlu R; Özhak Baysan B; Gültekin M; Çolak D
    Mikrobiyol Bul; 2014 Jul; 48(3):429-37. PubMed ID: 25052109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island.
    Karatapanis S; Tsoplou P; Papastergiou V; Vasiageorgi A; Stampori M; Saitis I; Tsitsopoulos E; Lisgos P; Skorda L; Ketikoglou I; Goulis I
    J Med Virol; 2012 Feb; 84(2):223-8. PubMed ID: 22170541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.
    Di Tommaso L; Macchia S; Morandi L; Leoncini S; Pession A; Dal Monte PR; Foschini MP
    Int J Surg Pathol; 2003 Jul; 11(3):197-204. PubMed ID: 12894351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study).
    Aguilera A; Navarro D; Rodríguez-Frias F; Viciana I; Martínez-Sapiña AM; Rodríguez MJ; Martró E; Lozano MC; Coletta E; Cardeñoso L; Suárez A; Trigo M; Rodríguez-Granjer J; Montiel N; de la Iglesia A; Alados JC; Vegas C; Bernal S; Fernández-Cuenca F; Pena MJ; Reina G; García-Bujalance S; Echevarria MJ; Benítez L; Pérez-Castro S; Ocete D; García-Arata I; Guerrero C; Rodríguez-Iglesias M; Casas P; García F
    J Viral Hepat; 2017 Sep; 24(9):725-732. PubMed ID: 28248445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping.
    Rodriguez-Frias F; Nieto-Aponte L; Gregori J; Garcia-Cehic D; Casillas R; Tabernero D; Homs M; Blasi M; Vila M; Chen Q; Vargas V; Castells L; Viladomiu L; Genesca J; Minguez B; Augustin S; Riveiro-Barciela M; Carbonell J; Perales C; Soria ME; Asensio M; Llorens M; Ordeig L; Godoy C; Buti M; Esteban R; Pumarola T; Esteban JI; Quer J
    Clin Microbiol Infect; 2017 Oct; 23(10):775.e1-775.e6. PubMed ID: 28192235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Mixed Hepatitis C Virus Genotype Infection and Its Effect on the Response to Direct-Acting Antivirals Therapy.
    Hayashi K; Tachi K; Shimizu Y; Nagano K; Ishizu Y; Kuzuya T; Honda T; Ishigami M; Hirooka Y; Hattori M; Goto H
    Intervirology; 2019; 62(1):23-29. PubMed ID: 31207601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Toro C; Sheldon J; García-Samaniego J; Ríos P; Soriano V
    J Infect; 2007 Feb; 54(2):173-9. PubMed ID: 16569433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles and clinical management of hepatitis C patients in Spain: disHCovery study.
    Buti M; Franco A; Carmona I; Sánchez-Ruano JJ; Sansó A; Berenguer M; García-Buey L; Hernández-Guerra M; Morillas RM; Ledesma F; Esteban R;
    Rev Esp Quimioter; 2015 Jun; 28(3):145-53. PubMed ID: 26032999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.
    Tan YW; Tao Y; Liu LG; Ye Y; Zhou XB; Chen L; He C
    World J Gastroenterol; 2018 Mar; 24(11):1250-1258. PubMed ID: 29568205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early virological response in 1220 patients with HCV (genotype lb) chronic hepatitis and cirrhosis treated with PegInterferon plus Ribavirin.
    Pascu O; Voiculescu M; Gheorghe L; Micu L; Seicean A; Iliescu L; Mocan T; Ceauşu E; Mateescu B
    Rom J Intern Med; 2011; 49(2):105-12. PubMed ID: 22303601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
    el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
    Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing.
    Nieto-Aponte L; Quer J; Ruiz-Ripa A; Tabernero D; Gonzalez C; Gregori J; Vila M; Asensio M; Garcia-Cehic D; Ruiz G; Chen Q; Ordeig L; Llorens M; Saez M; Esteban JI; Esteban R; Buti M; Pumarola T; Rodriguez-Frias F
    J Clin Microbiol; 2017 Feb; 55(2):504-509. PubMed ID: 27927921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
    Hézode C; Fontaine H; Dorival C; Zoulim F; Larrey D; Canva V; De Ledinghen V; Poynard T; Samuel D; Bourliere M; Alric L; Raabe JJ; Zarski JP; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Chazouilleres O; Abergel A; Guyader D; Metivier S; Tran A; Di Martino V; Causse X; Dao T; Lucidarme D; Portal I; Cacoub P; Gournay J; Grando-Lemaire V; Hillon P; Attali P; Fontanges T; Rosa I; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP;
    Gastroenterology; 2014 Jul; 147(1):132-142.e4. PubMed ID: 24704719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti-Hepatitis C Virus Therapy in Patients With Advanced Liver Disease.
    Kattakuzhy S; Wilson E; Sidharthan S; Sims Z; McLaughlin M; Price A; Silk R; Gross C; Akoth E; McManus M; Emmanuel B; Shrivastava S; Tang L; Nelson A; Teferi G; Chavez J; Lam B; Mo H; Osinusi A; Polis MA; Masur H; Kohli A; Kottilil S
    Clin Infect Dis; 2016 Feb; 62(4):440-447. PubMed ID: 26503379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.